Melatonin for Traumatic Brain Injury
This trial will test if a melatonin intervention can help reduce sleep wake disturbances for pediatric TBI survivors, which will be measured by questionnaires and activity monitors.
- Traumatic Brain Injury
- Critical Illness
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Side effects dataFrom 2017 Phase 3 trial • 709 Patients • NCT00668707
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Am I qualified to participate in this scientific experiment?
"This medical trial requires its participants to be suffering from a severe illness and aged between 6 and 18. The total capacity of this experiment is 110 individuals."
Can individuals expect any unwanted side effects from a sleep management regimen?
"The risk associated with the sleep management plan is estimated to be a 2 according to our team at Power. This Phase 2 trial has some evidence in favour of safety, but no data demonstrating efficacy yet."
Is there room for more participants in this experiment?
"According to clinicaltrials.gov, this research project is not taking on any new patients at present; the study was initially posted on September 1st 2022 and recently updated on August 11th 2022. Despite this, there are 1198 other studies currently recruiting participants."
What objectives is this scientific experiment seeking to accomplish?
"During this 6-month medical trial, the principal objective is to evaluate retention. Other desirable outcomes encompass assessment of adverse events both at baseline and follow-up, as well as fatigue scores obtained via a parent proxy report using the PedsQL Multidimensional Fatigue Scale with 0 representing no function and 100 indicating optimal functioning."
Does this experiment accept elderly participants?
"The age criteria for this clinical trial necessitates that participants are between 6 and 18 years old. There is an abundance of trials devoted to children, with 204 studies targeting those below the age of 18, as well as a plethora of 929 research initiatives for seniors above 65."